Financial Analysis: biote (NASDAQ:BTMD) versus Ramsay Health Care (OTCMKTS:RMSYF)

biote (NASDAQ:BTMD) and Ramsay Health Care (OTCMKTS:RMSYF) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, risk, valuation, analyst recommendations, institutional ownership and dividends.

Valuation & Earnings

This table compares biote and Ramsay Health Care”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
biote	$192.22 million	0.29	$27.05 million	$0.11	14.09
Ramsay Health Care	N/A	N/A	N/A	$1.43	25.60

biote has higher revenue and earnings than Ramsay Health Care. biote is trading at a lower price-to-earnings ratio than Ramsay Health Care, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of current recommendations for biote and Ramsay Health Care, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
biote	1	1	1	1	2.50
Ramsay Health Care	0	0	1	0	3.00

biote presently has a consensus price target of $2.50, suggesting a potential upside of 61.29%. Ramsay Health Care has a consensus price target of $54.10, suggesting a potential upside of 47.75%. Given biote’s higher possible upside, analysts clearly believe biote is more favorable than Ramsay Health Care.

Insider & Institutional Ownership

21.7% of biote shares are owned by institutional investors. Comparatively, 13.2% of Ramsay Health Care shares are owned by institutional investors. 32.4% of biote shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Profitability

This table compares biote and Ramsay Health Care’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
biote	3.19%	-22.33%	12.10%
Ramsay Health Care	N/A	N/A	N/A

Summary

biote beats Ramsay Health Care on 7 of the 11 factors compared between the two stocks.

About biote

biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification services; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female. The company was founded in 2012 and is headquartered in Irving, Texas.

About Ramsay Health Care

Ramsay Health Care Limited owns and operates hospitals. The company offers health care services to public and private patients. It operates facilities in approximately 530 locations in the Asia Pacific, the United Kingdom, France, and Nordics. Ramsay Health Care Limited was founded in 1964 and is based in Sydney, Australia.